VINCERX PHARMA INC (VINC) Stock Balance Sheet
NASDAQ:VINC - Nasdaq - US92731L1061 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | 700.00K | |||
| Cash Equivalents | 2.94M | 12.78M | 11.70M | 111.50M | 61.80M | |||
| Marketable Securities | 7.14M | 0.00 | 40.80M | N/A | N/A | |||
| Receivables | 1.06M | 1.29M | 1.40M | N/A | N/A | |||
| Other Current Assets | 599.00K | 657.00K | 2.10M | 400.00K | 100.00K | |||
| Total Current Assets | 11.75M | 14.73M | 56.00M | 111.80M | 800.00K | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.52M | 2.33M | 3.20M | 4.20M | N/A | |||
| Investments And Advances | N/A | N/A | N/A | N/A | 65.70M | |||
| Other Non-Current Assets | 173.00K | 1.16M | 100.00K | 1.70M | 100.00K | |||
| Total Non-Current Assets | 3.20M | 3.48M | 3.30M | 5.90M | 65.70M | |||
| TOTAL ASSETS | 14.95M | 18.22M | 59.30M | 117.70M | 66.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 3.00M | 2.92M | 5.90M | 700.00K | N/A | |||
| Accounts Payable | 1.96M | 2.50M | 3.10M | 6.70M | 100.00K | |||
| Other Current Liabilities | 463.00K | 191.00K | 100.00K | 6.40M | 0.00 | |||
| Total Current Liabilities | 5.42M | 5.61M | 9.20M | 13.90M | 100.00K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 415.00K | 1.39M | 2.50M | 3.40M | 3.30M | |||
| Total Non-Current Liabilities | 415.00K | 1.39M | 2.40M | 3.50M | 3.30M | |||
| TOTAL LIABILITIES | 5.84M | 7.00M | 11.60M | 17.40M | 3.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -181.19M | -159.11M | -121.30M | -56.00M | -100.00K | |||
| Additional Paid In Capital | 190.19M | 170.32M | 169.00M | 156.30M | 5.10M | |||
| Common Shares | 3.00K | 2.00K | 0.00 | 0.00 | 58.10M | |||
| Other Shareholders' Equity | 104.00K | 8.00K | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 31.40M | 21.41M | 21.20M | 21.10M | 8.20M | |||
| Tangible Book Value per Share | 0.29 | 0.52 | 2.25 | 4.75 | 7.70 | |||
| Total Shareholders' Equity | 9.11M | 11.22M | 47.70M | 100.30M | 63.10M | |||
| TOTAL LIABILITIES AND EQUITY | 14.95M | 18.22M | 59.30M | 117.70M | 66.50M | |||
| Statistics | ||||||||
| Current Ratio | 2.17 | 2.63 | 6.09 | 8.04 | 8.00 | |||
| Return On Assets (ROA) | -180.84% | -220.44% | -110.24% | -33.40% | -0.18% | |||
| Return On Equity (ROE) | -296.77% | -357.84% | -137.04% | -39.19% | -0.19% | |||
All data in USD , ROIC based on taxRate of 0.21